nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—uterine cancer—germ cell cancer	0.726	1	CtDrD
Medroxyprogesterone Acetate—CYP2C8—Ifosfamide—germ cell cancer	0.0273	0.3	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Ifosfamide—germ cell cancer	0.0191	0.21	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Etoposide—germ cell cancer	0.0131	0.144	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Ifosfamide—germ cell cancer	0.0111	0.122	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Cisplatin—germ cell cancer	0.00927	0.102	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Vinblastine—germ cell cancer	0.00588	0.0646	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Etoposide—germ cell cancer	0.00529	0.0582	CbGbCtD
Medroxyprogesterone Acetate—SHBG—seminiferous tubule of testis—germ cell cancer	0.00438	0.082	CbGeAlD
Medroxyprogesterone Acetate—AR—scrotum—germ cell cancer	0.00404	0.0757	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—cardial valve—germ cell cancer	0.00404	0.0756	CbGeAlD
Medroxyprogesterone Acetate—AR—seminiferous tubule of testis—germ cell cancer	0.00314	0.0588	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—Podofilox—Etoposide—germ cell cancer	0.00146	0.539	CbGdCrCtD
Medroxyprogesterone Acetate—PGR—Nuclear Receptors—NR0B1—germ cell cancer	0.00137	0.0576	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Vincristine—Vinblastine—germ cell cancer	0.00125	0.461	CbGdCrCtD
Medroxyprogesterone Acetate—HSD3B2—gonad—germ cell cancer	0.00117	0.0219	CbGeAlD
Medroxyprogesterone Acetate—PGR—Ovarian Infertility Genes—INHA—germ cell cancer	0.00116	0.0487	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—pituitary gland—germ cell cancer	0.00114	0.0214	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—Metapathway biotransformation—NAT9—germ cell cancer	0.00111	0.0469	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00108	0.0455	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Nuclear Receptors—NR0B1—germ cell cancer	0.00104	0.0439	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—adrenal gland—germ cell cancer	0.00102	0.0191	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—female gonad—germ cell cancer	0.000951	0.0178	CbGeAlD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.000903	0.038	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—endocrine gland—germ cell cancer	0.000884	0.0165	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—urine—germ cell cancer	0.000879	0.0164	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—head—germ cell cancer	0.000873	0.0163	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—urine—germ cell cancer	0.000872	0.0163	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—testis—germ cell cancer	0.000843	0.0158	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—germ cell cancer	0.000826	0.0154	CbGeAlD
Medroxyprogesterone Acetate—AR—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000825	0.0347	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—GDF3—germ cell cancer	0.00082	0.0345	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptors—NR0B1—germ cell cancer	0.000804	0.0338	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.0008	0.0336	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptors—NR0B1—germ cell cancer	0.000792	0.0333	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—trigeminal ganglion—germ cell cancer	0.000753	0.0141	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—urine—germ cell cancer	0.000665	0.0124	CbGeAlD
Medroxyprogesterone Acetate—SHBG—neck—germ cell cancer	0.000656	0.0123	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—germ cell cancer	0.000646	0.0121	CbGeAlD
Medroxyprogesterone Acetate—ESR1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000635	0.0267	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—brain—germ cell cancer	0.000633	0.0118	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.000626	0.0263	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—lymph node—germ cell cancer	0.000611	0.0114	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Regulation of Androgen receptor activity—NR0B1—germ cell cancer	0.000607	0.0255	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—decidua—germ cell cancer	0.000561	0.0105	CbGeAlD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—NR0B1—germ cell cancer	0.00053	0.0223	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.00052	0.0219	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—brainstem—germ cell cancer	0.000501	0.00937	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—uterus—germ cell cancer	0.00049	0.00918	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—pituitary gland—germ cell cancer	0.000482	0.00901	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—medulla oblongata—germ cell cancer	0.000465	0.0087	CbGeAlD
Medroxyprogesterone Acetate—ESR1—neck—germ cell cancer	0.000462	0.00864	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—SOX17—germ cell cancer	0.00045	0.0189	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—NANOG—germ cell cancer	0.000431	0.0181	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—adrenal gland—germ cell cancer	0.00043	0.00805	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—midbrain—germ cell cancer	0.000425	0.00795	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—bone marrow—germ cell cancer	0.000416	0.00779	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—POU5F1—germ cell cancer	0.000415	0.0175	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—spinal cord—germ cell cancer	0.000414	0.00775	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—female gonad—germ cell cancer	0.000401	0.00751	CbGeAlD
Medroxyprogesterone Acetate—ESR1—embryo—germ cell cancer	0.000385	0.00721	CbGeAlD
Medroxyprogesterone Acetate—PGR—decidua—germ cell cancer	0.00038	0.0071	CbGeAlD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.000378	0.0159	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—gonad—germ cell cancer	0.000371	0.00694	CbGeAlD
Medroxyprogesterone Acetate—SHBG—uterus—germ cell cancer	0.000369	0.0069	CbGeAlD
Medroxyprogesterone Acetate—SHBG—pituitary gland—germ cell cancer	0.000362	0.00677	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—testis—germ cell cancer	0.000356	0.00666	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brainstem—germ cell cancer	0.000353	0.0066	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—neck—germ cell cancer	0.000341	0.00638	CbGeAlD
Medroxyprogesterone Acetate—PGR—uterus—germ cell cancer	0.000332	0.00621	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—germ cell cancer	0.000329	0.00615	CbGeAlD
Medroxyprogesterone Acetate—SHBG—Nongenotropic Androgen signaling—HRAS—germ cell cancer	0.000327	0.0137	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—pituitary gland—germ cell cancer	0.000326	0.0061	CbGeAlD
Medroxyprogesterone Acetate—SHBG—adrenal gland—germ cell cancer	0.000323	0.00605	CbGeAlD
Medroxyprogesterone Acetate—AR—telencephalon—germ cell cancer	0.000319	0.00597	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000313	0.0132	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—telencephalon—germ cell cancer	0.000313	0.00586	CbGeAlD
Medroxyprogesterone Acetate—SHBG—bone marrow—germ cell cancer	0.000313	0.00585	CbGeAlD
Medroxyprogesterone Acetate—AR—skin of body—germ cell cancer	0.000305	0.0057	CbGeAlD
Medroxyprogesterone Acetate—AR—decidua—germ cell cancer	0.000302	0.00566	CbGeAlD
Medroxyprogesterone Acetate—SHBG—female gonad—germ cell cancer	0.000302	0.00564	CbGeAlD
Medroxyprogesterone Acetate—ESR1—decidua—germ cell cancer	0.000297	0.00556	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—trigeminal ganglion—germ cell cancer	0.000294	0.00551	CbGeAlD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000292	0.0123	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—adrenal gland—germ cell cancer	0.000291	0.00545	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—embryo—germ cell cancer	0.000284	0.00532	CbGeAlD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000281	0.0118	CbGpPWpGaD
Medroxyprogesterone Acetate—SHBG—endocrine gland—germ cell cancer	0.00028	0.00525	CbGeAlD
Medroxyprogesterone Acetate—PGR—female gonad—germ cell cancer	0.000272	0.00508	CbGeAlD
Medroxyprogesterone Acetate—SHBG—testis—germ cell cancer	0.000267	0.005	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—germ cell cancer	0.000267	0.00499	CbGeAlD
Medroxyprogesterone Acetate—AR—gonad—germ cell cancer	0.000266	0.00498	CbGeAlD
Medroxyprogesterone Acetate—AR—uterus—germ cell cancer	0.000265	0.00495	CbGeAlD
Medroxyprogesterone Acetate—ESR1—gonad—germ cell cancer	0.000261	0.00489	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brainstem—germ cell cancer	0.00026	0.00487	CbGeAlD
Medroxyprogesterone Acetate—AR—pituitary gland—germ cell cancer	0.00026	0.00486	CbGeAlD
Medroxyprogesterone Acetate—ESR1—uterus—germ cell cancer	0.00026	0.00486	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lymph node—germ cell cancer	0.000258	0.00483	CbGeAlD
Medroxyprogesterone Acetate—ESR1—pituitary gland—germ cell cancer	0.000255	0.00477	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000255	0.0107	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—eye—germ cell cancer	0.000254	0.00474	CbGeAlD
Medroxyprogesterone Acetate—PGR—endocrine gland—germ cell cancer	0.000253	0.00473	CbGeAlD
Medroxyprogesterone Acetate—PGR—head—germ cell cancer	0.000249	0.00467	CbGeAlD
Medroxyprogesterone Acetate—SHBG—cerebellum—germ cell cancer	0.000247	0.00462	CbGeAlD
Medroxyprogesterone Acetate—PGR—testis—germ cell cancer	0.000241	0.00451	CbGeAlD
Medroxyprogesterone Acetate—Progesterone—SLC22A3—germ cell cancer	0.000241	0.514	CrCbGaD
Medroxyprogesterone Acetate—AR—adrenal gland—germ cell cancer	0.000232	0.00434	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—telencephalon—germ cell cancer	0.000231	0.00432	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—SOX2—germ cell cancer	0.00023	0.00968	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—adrenal gland—germ cell cancer	0.000228	0.00426	CbGeAlD
Medroxyprogesterone Acetate—Testosterone—SLC22A3—germ cell cancer	0.000228	0.486	CrCbGaD
Medroxyprogesterone Acetate—AR—spinal cord—germ cell cancer	0.000224	0.00418	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—germ cell cancer	0.000223	0.00416	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000222	0.00933	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—germ cell cancer	0.000221	0.00928	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—skin of body—germ cell cancer	0.000221	0.00413	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—decidua—germ cell cancer	0.000219	0.0041	CbGeAlD
Medroxyprogesterone Acetate—AR—female gonad—germ cell cancer	0.000216	0.00405	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000213	0.00898	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—female gonad—germ cell cancer	0.000212	0.00398	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—pituitary gland—germ cell cancer	0.00021	0.00393	CbGeAlD
Medroxyprogesterone Acetate—AR—endocrine gland—germ cell cancer	0.000201	0.00377	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—germ cell cancer	0.000201	0.00375	CbGeAlD
Medroxyprogesterone Acetate—AR—head—germ cell cancer	0.000199	0.00372	CbGeAlD
Medroxyprogesterone Acetate—ESR1—endocrine gland—germ cell cancer	0.000198	0.0037	CbGeAlD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.000195	0.00822	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—head—germ cell cancer	0.000195	0.00365	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—gonad—germ cell cancer	0.000193	0.00361	CbGeAlD
Medroxyprogesterone Acetate—AR—testis—germ cell cancer	0.000192	0.00359	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000192	0.00806	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—uterus—germ cell cancer	0.000192	0.00359	CbGeAlD
Medroxyprogesterone Acetate—ESR1—testis—germ cell cancer	0.000188	0.00353	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—pituitary gland—germ cell cancer	0.000188	0.00352	CbGeAlD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000187	0.00787	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—medulla oblongata—germ cell cancer	0.000182	0.0034	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—germ cell cancer	0.000181	0.00338	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymph node—germ cell cancer	0.000175	0.00327	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cerebellum—germ cell cancer	0.000174	0.00326	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000168	0.00708	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—adrenal gland—germ cell cancer	0.000168	0.00315	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—midbrain—germ cell cancer	0.000166	0.00311	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—endocrine gland—germ cell cancer	0.000163	0.00305	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—bone marrow—germ cell cancer	0.000163	0.00304	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—spinal cord—germ cell cancer	0.000162	0.00303	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—Circadian Clock—AVP—germ cell cancer	0.000161	0.00676	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—female gonad—germ cell cancer	0.000157	0.00293	CbGeAlD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000156	0.00657	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—testis—germ cell cancer	0.000155	0.0029	CbGeAlD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—FGF4—germ cell cancer	0.000154	0.00646	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—endocrine gland—germ cell cancer	0.000146	0.00273	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—endocrine gland—germ cell cancer	0.000145	0.00271	CbGeAlD
Medroxyprogesterone Acetate—AR—brain—germ cell cancer	0.000144	0.00269	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—head—germ cell cancer	0.000144	0.00269	CbGeAlD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000142	0.00599	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—brain—germ cell cancer	0.000141	0.00264	CbGeAlD
Medroxyprogesterone Acetate—AR—lymph node—germ cell cancer	0.000139	0.0026	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—testis—germ cell cancer	0.000139	0.0026	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymph node—germ cell cancer	0.000137	0.00256	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cerebellum—germ cell cancer	0.000128	0.0024	CbGeAlD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—KITLG—germ cell cancer	0.000126	0.00531	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000118	0.00498	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—brain—germ cell cancer	0.000116	0.00218	CbGeAlD
Medroxyprogesterone Acetate—Infection—Dactinomycin—germ cell cancer	0.000111	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Ifosfamide—germ cell cancer	0.000111	0.00108	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—endocrine gland—germ cell cancer	0.00011	0.00206	CbGeAlD
Medroxyprogesterone Acetate—Alopecia—Cisplatin—germ cell cancer	0.00011	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—Hepatic failure—Methotrexate—germ cell cancer	0.00011	0.00107	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.00011	0.00462	CbGpPWpGaD
Medroxyprogesterone Acetate—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00011	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000109	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Ifosfamide—germ cell cancer	0.000109	0.00106	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Cisplatin—germ cell cancer	0.000108	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Cisplatin—germ cell cancer	0.000108	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000108	0.00455	CbGpPWpGaD
Medroxyprogesterone Acetate—Erythema multiforme—Etoposide—germ cell cancer	0.000108	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Bleomycin—germ cell cancer	0.000108	0.00105	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Bleomycin—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Ifosfamide—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Ifosfamide—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Ifosfamide—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Cisplatin—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Dactinomycin—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Etoposide—germ cell cancer	0.000107	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000106	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SLC2A3—germ cell cancer	0.000106	0.00447	CbGpPWpGaD
Medroxyprogesterone Acetate—Cardiac disorder—Etoposide—germ cell cancer	0.000106	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Ifosfamide—germ cell cancer	0.000106	0.00103	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Vinblastine—germ cell cancer	0.000105	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SLC22A3—germ cell cancer	0.000105	0.0044	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Bleomycin—germ cell cancer	0.000104	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—brain—germ cell cancer	0.000104	0.00195	CbGeAlD
Medroxyprogesterone Acetate—Visual disturbance—Methotrexate—germ cell cancer	0.000104	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Cisplatin—germ cell cancer	0.000104	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Etoposide—germ cell cancer	0.000104	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Ifosfamide—germ cell cancer	0.000104	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Etoposide—germ cell cancer	0.000103	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Etoposide—germ cell cancer	0.000103	0.000998	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000103	0.000996	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Ifosfamide—germ cell cancer	0.000103	0.000996	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Etoposide—germ cell cancer	0.000102	0.000994	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000102	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000102	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Vinblastine—germ cell cancer	0.000102	0.00099	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Ifosfamide—germ cell cancer	0.000102	0.00099	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Cisplatin—germ cell cancer	0.000102	0.000986	CcSEcCtD
Medroxyprogesterone Acetate—AR—Nongenotropic Androgen signaling—HRAS—germ cell cancer	0.000101	0.00425	CbGpPWpGaD
Medroxyprogesterone Acetate—Alopecia—Etoposide—germ cell cancer	0.000101	0.000979	CcSEcCtD
Medroxyprogesterone Acetate—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000101	0.000979	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—lymph node—germ cell cancer	0.000101	0.00189	CbGeAlD
Medroxyprogesterone Acetate—Nervous system disorder—Ifosfamide—germ cell cancer	0.000101	0.000977	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Cisplatin—germ cell cancer	0.000101	0.000976	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000101	0.000975	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Cisplatin—germ cell cancer	0.0001	0.000973	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Ifosfamide—germ cell cancer	9.97e-05	0.000968	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Ifosfamide—germ cell cancer	9.93e-05	0.000963	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Bleomycin—germ cell cancer	9.9e-05	0.000961	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Methotrexate—germ cell cancer	9.88e-05	0.000959	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Ifosfamide—germ cell cancer	9.79e-05	0.00095	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Cisplatin—germ cell cancer	9.78e-05	0.000949	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Dactinomycin—germ cell cancer	9.74e-05	0.000945	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Vinblastine—germ cell cancer	9.73e-05	0.000944	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Etoposide—germ cell cancer	9.73e-05	0.000944	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Dactinomycin—germ cell cancer	9.66e-05	0.000937	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Etoposide—germ cell cancer	9.61e-05	0.000933	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Ifosfamide—germ cell cancer	9.6e-05	0.000931	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Etoposide—germ cell cancer	9.55e-05	0.000927	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Bleomycin—germ cell cancer	9.54e-05	0.000926	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Bleomycin—germ cell cancer	9.5e-05	0.000922	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.47e-05	0.00398	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	9.46e-05	0.00398	CbGpPWpGaD
Medroxyprogesterone Acetate—Irritability—Methotrexate—germ cell cancer	9.43e-05	0.000915	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Vinblastine—germ cell cancer	9.41e-05	0.000913	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Cisplatin—germ cell cancer	9.4e-05	0.000912	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—FGFR3—germ cell cancer	9.37e-05	0.00394	CbGpPWpGaD
Medroxyprogesterone Acetate—Mood swings—Methotrexate—germ cell cancer	9.36e-05	0.000908	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	9.36e-05	0.000908	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Methotrexate—germ cell cancer	9.29e-05	0.000902	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Cisplatin—germ cell cancer	9.23e-05	0.000896	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Dactinomycin—germ cell cancer	9.23e-05	0.000896	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Ifosfamide—germ cell cancer	9.22e-05	0.000895	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Etoposide—germ cell cancer	9.22e-05	0.000895	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Cisplatin—germ cell cancer	9.2e-05	0.000893	CcSEcCtD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—AVP—germ cell cancer	9.2e-05	0.00387	CbGpPWpGaD
Medroxyprogesterone Acetate—Anaemia—Etoposide—germ cell cancer	9.18e-05	0.000891	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	9.17e-05	0.00089	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Dactinomycin—germ cell cancer	9.16e-05	0.000889	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Ifosfamide—germ cell cancer	9.15e-05	0.000888	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Ifosfamide—germ cell cancer	9.13e-05	0.000886	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Cisplatin—germ cell cancer	9.12e-05	0.000885	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Vinblastine—germ cell cancer	9.05e-05	0.000878	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—FGF4—germ cell cancer	9.01e-05	0.00379	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR0B1—germ cell cancer	9e-05	0.00379	CbGpPWpGaD
Medroxyprogesterone Acetate—Malaise—Etoposide—germ cell cancer	8.96e-05	0.000869	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Methotrexate—germ cell cancer	8.93e-05	0.000867	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Etoposide—germ cell cancer	8.93e-05	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Ifosfamide—germ cell cancer	8.93e-05	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Vinblastine—germ cell cancer	8.91e-05	0.000865	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	8.87e-05	0.00086	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Dactinomycin—germ cell cancer	8.86e-05	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Dactinomycin—germ cell cancer	8.86e-05	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Ifosfamide—germ cell cancer	8.85e-05	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Cisplatin—germ cell cancer	8.85e-05	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Cisplatin—germ cell cancer	8.85e-05	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Bleomycin—germ cell cancer	8.85e-05	0.000859	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Cisplatin—germ cell cancer	8.79e-05	0.000853	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Ifosfamide—germ cell cancer	8.78e-05	0.000852	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Etoposide—germ cell cancer	8.73e-05	0.000847	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Cisplatin—germ cell cancer	8.68e-05	0.000842	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Cisplatin—germ cell cancer	8.67e-05	0.000841	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Cisplatin—germ cell cancer	8.64e-05	0.000838	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Bleomycin—germ cell cancer	8.62e-05	0.000836	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Etoposide—germ cell cancer	8.61e-05	0.000835	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—KIT—germ cell cancer	8.61e-05	0.00362	CbGpPWpGaD
Medroxyprogesterone Acetate—Skin disorder—Cisplatin—germ cell cancer	8.6e-05	0.000834	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Cisplatin—germ cell cancer	8.56e-05	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Methotrexate—germ cell cancer	8.54e-05	0.000829	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CRABP1—germ cell cancer	8.54e-05	0.00359	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Bleomycin—germ cell cancer	8.5e-05	0.000825	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Ifosfamide—germ cell cancer	8.46e-05	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Etoposide—germ cell cancer	8.46e-05	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Vinblastine—germ cell cancer	8.45e-05	0.00082	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Cisplatin—germ cell cancer	8.44e-05	0.000819	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	8.4e-05	0.000815	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Ifosfamide—germ cell cancer	8.4e-05	0.000815	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Etoposide—germ cell cancer	8.36e-05	0.000811	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Cisplatin—germ cell cancer	8.27e-05	0.000803	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Dactinomycin—germ cell cancer	8.26e-05	0.000801	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal discomfort—Methotrexate—germ cell cancer	8.19e-05	0.000795	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Etoposide—germ cell cancer	8.18e-05	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Ifosfamide—germ cell cancer	8.16e-05	0.000791	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Ifosfamide—germ cell cancer	8.12e-05	0.000788	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Ifosfamide—germ cell cancer	8.12e-05	0.000788	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Etoposide—germ cell cancer	8.11e-05	0.000787	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Cisplatin—germ cell cancer	8.07e-05	0.000783	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Etoposide—germ cell cancer	8.06e-05	0.000782	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Dactinomycin—germ cell cancer	8.04e-05	0.00078	CcSEcCtD
Medroxyprogesterone Acetate—Dysuria—Methotrexate—germ cell cancer	7.99e-05	0.000775	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Cisplatin—germ cell cancer	7.95e-05	0.000771	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Etoposide—germ cell cancer	7.94e-05	0.00077	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Methotrexate—germ cell cancer	7.94e-05	0.00077	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Etoposide—germ cell cancer	7.92e-05	0.000768	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Cisplatin—germ cell cancer	7.89e-05	0.000766	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Etoposide—germ cell cancer	7.88e-05	0.000764	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Etoposide—germ cell cancer	7.84e-05	0.000761	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—DNMT3L—germ cell cancer	7.81e-05	0.00328	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—MYC—germ cell cancer	7.78e-05	0.00327	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Etoposide—germ cell cancer	7.73e-05	0.00075	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Cisplatin—germ cell cancer	7.7e-05	0.000747	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Dactinomycin—germ cell cancer	7.67e-05	0.000744	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Cisplatin—germ cell cancer	7.64e-05	0.000742	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Bleomycin—germ cell cancer	7.64e-05	0.000741	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—MYC—germ cell cancer	7.63e-05	0.00321	CbGpPWpGaD
Medroxyprogesterone Acetate—Infestation—Methotrexate—germ cell cancer	7.62e-05	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Methotrexate—germ cell cancer	7.62e-05	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Methotrexate—germ cell cancer	7.62e-05	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Depression—Methotrexate—germ cell cancer	7.59e-05	0.000737	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Etoposide—germ cell cancer	7.58e-05	0.000735	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Bleomycin—germ cell cancer	7.58e-05	0.000735	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Bleomycin—germ cell cancer	7.57e-05	0.000734	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Ifosfamide—germ cell cancer	7.57e-05	0.000734	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Methotrexate—germ cell cancer	7.42e-05	0.00072	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—KITLG—germ cell cancer	7.4e-05	0.00311	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	7.39e-05	0.00311	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Ifosfamide—germ cell cancer	7.37e-05	0.000715	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Methotrexate—germ cell cancer	7.3e-05	0.000708	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Cisplatin—germ cell cancer	7.3e-05	0.000708	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Etoposide—germ cell cancer	7.28e-05	0.000707	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ifosfamide—germ cell cancer	7.26e-05	0.000705	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—RARS—germ cell cancer	7.26e-05	0.00305	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	7.23e-05	0.00304	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Etoposide—germ cell cancer	7.23e-05	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Etoposide—germ cell cancer	7.21e-05	0.0007	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Methotrexate—germ cell cancer	7.2e-05	0.000699	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Methotrexate—germ cell cancer	7.18e-05	0.000697	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Bleomycin—germ cell cancer	7.14e-05	0.000692	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Dactinomycin—germ cell cancer	7.12e-05	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Dactinomycin—germ cell cancer	7.07e-05	0.000685	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Etoposide—germ cell cancer	7.05e-05	0.000684	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ifosfamide—germ cell cancer	7.03e-05	0.000682	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Etoposide—germ cell cancer	7e-05	0.000679	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Cisplatin—germ cell cancer	7e-05	0.000679	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Etoposide—germ cell cancer	6.99e-05	0.000678	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—AVP—germ cell cancer	6.98e-05	0.00294	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Etoposide—germ cell cancer	6.94e-05	0.000673	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Methotrexate—germ cell cancer	6.87e-05	0.000667	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—NR0B1—germ cell cancer	6.86e-05	0.00289	CbGpPWpGaD
Medroxyprogesterone Acetate—Haemorrhage—Methotrexate—germ cell cancer	6.84e-05	0.000663	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Methotrexate—germ cell cancer	6.84e-05	0.000663	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ifosfamide—germ cell cancer	6.79e-05	0.000659	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Methotrexate—germ cell cancer	6.79e-05	0.000658	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—germ cell cancer	6.75e-05	0.000655	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—germ cell cancer	6.7e-05	0.00065	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Etoposide—germ cell cancer	6.68e-05	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Dactinomycin—germ cell cancer	6.66e-05	0.000646	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Etoposide—germ cell cancer	6.63e-05	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—germ cell cancer	6.59e-05	0.000639	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ifosfamide—germ cell cancer	6.53e-05	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Cisplatin—germ cell cancer	6.52e-05	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ifosfamide—germ cell cancer	6.47e-05	0.000628	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ifosfamide—germ cell cancer	6.47e-05	0.000628	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—germ cell cancer	6.47e-05	0.000627	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Etoposide—germ cell cancer	6.44e-05	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Etoposide—germ cell cancer	6.41e-05	0.000622	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Etoposide—germ cell cancer	6.41e-05	0.000622	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—germ cell cancer	6.39e-05	0.00062	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—germ cell cancer	6.38e-05	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Cisplatin—germ cell cancer	6.35e-05	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—germ cell cancer	6.35e-05	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—SLC2A3—germ cell cancer	6.27e-05	0.00264	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—germ cell cancer	6.27e-05	0.00264	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	6.23e-05	0.00262	CbGpPWpGaD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—germ cell cancer	6.2e-05	0.000602	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—germ cell cancer	6.18e-05	0.000599	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—germ cell cancer	6.16e-05	0.000598	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—germ cell cancer	6.14e-05	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ifosfamide—germ cell cancer	6.1e-05	0.000592	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Cisplatin—germ cell cancer	6.06e-05	0.000588	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—germ cell cancer	6.04e-05	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	6.03e-05	0.00254	CbGpPWpGaD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—germ cell cancer	5.99e-05	0.000581	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Etoposide—germ cell cancer	5.98e-05	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	5.97e-05	0.00251	CbGpPWpGaD
Medroxyprogesterone Acetate—Erythema—Methotrexate—germ cell cancer	5.95e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—germ cell cancer	5.95e-05	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—DNMT3L—germ cell cancer	5.95e-05	0.0025	CbGpPWpGaD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—germ cell cancer	5.83e-05	0.000566	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Etoposide—germ cell cancer	5.82e-05	0.000565	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Methotrexate—germ cell cancer	5.76e-05	0.000559	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Etoposide—germ cell cancer	5.74e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	5.68e-05	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Cisplatin—germ cell cancer	5.63e-05	0.000546	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Cisplatin—germ cell cancer	5.58e-05	0.000542	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Cisplatin—germ cell cancer	5.58e-05	0.000541	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—MYC—germ cell cancer	5.55e-05	0.00234	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Etoposide—germ cell cancer	5.55e-05	0.000538	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—RARS—germ cell cancer	5.53e-05	0.00233	CbGpPWpGaD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—germ cell cancer	5.52e-05	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—FGFR3—germ cell cancer	5.5e-05	0.00231	CbGpPWpGaD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—germ cell cancer	5.5e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—germ cell cancer	5.37e-05	0.000521	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Etoposide—germ cell cancer	5.36e-05	0.00052	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—germ cell cancer	5.35e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—MYC—germ cell cancer	5.29e-05	0.00223	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR0B1—germ cell cancer	5.28e-05	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Cisplatin—germ cell cancer	5.26e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SLC2A3—germ cell cancer	5.25e-05	0.00221	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NR0B1—germ cell cancer	5.2e-05	0.00219	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SLC22A3—germ cell cancer	5.17e-05	0.00218	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MYC—germ cell cancer	5.17e-05	0.00217	CbGpPWpGaD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—germ cell cancer	5.16e-05	0.0005	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Etoposide—germ cell cancer	5.16e-05	0.0005	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Etoposide—germ cell cancer	5.11e-05	0.000496	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Etoposide—germ cell cancer	5.11e-05	0.000496	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MYC—germ cell cancer	5.09e-05	0.00214	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Etoposide—germ cell cancer	5.08e-05	0.000493	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—germ cell cancer	5.07e-05	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—germ cell cancer	5.07e-05	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—germ cell cancer	5.07e-05	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—KIT—germ cell cancer	5.05e-05	0.00213	CbGpPWpGaD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	5.03e-05	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—germ cell cancer	5.01e-05	0.000486	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—germ cell cancer	4.9e-05	0.000475	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—germ cell cancer	4.86e-05	0.000471	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methotrexate—germ cell cancer	4.83e-05	0.000468	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Etoposide—germ cell cancer	4.82e-05	0.000467	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—germ cell cancer	4.76e-05	0.000462	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—germ cell cancer	4.76e-05	0.000461	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—germ cell cancer	4.72e-05	0.000458	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—germ cell cancer	4.7e-05	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—germ cell cancer	4.63e-05	0.000449	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	4.6e-05	0.00193	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—DNMT3L—germ cell cancer	4.58e-05	0.00193	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—germ cell cancer	4.54e-05	0.00044	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	4.53e-05	0.00191	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—DNMT3L—germ cell cancer	4.51e-05	0.0019	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—germ cell cancer	4.43e-05	0.000429	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—germ cell cancer	4.39e-05	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—germ cell cancer	4.36e-05	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—germ cell cancer	4.33e-05	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—germ cell cancer	4.32e-05	0.000419	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—germ cell cancer	4.28e-05	0.000415	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RARS—germ cell cancer	4.26e-05	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—germ cell cancer	4.24e-05	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—germ cell cancer	4.22e-05	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CRABP1—germ cell cancer	4.22e-05	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RARS—germ cell cancer	4.19e-05	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.19e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—germ cell cancer	4.19e-05	0.000406	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—germ cell cancer	4.18e-05	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—germ cell cancer	4e-05	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—germ cell cancer	3.97e-05	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—germ cell cancer	3.86e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—HRAS—germ cell cancer	3.84e-05	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—germ cell cancer	3.84e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—germ cell cancer	3.84e-05	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—HRAS—germ cell cancer	3.72e-05	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	3.68e-05	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	3.63e-05	0.00153	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—FGF4—germ cell cancer	3.6e-05	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—germ cell cancer	3.58e-05	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—germ cell cancer	3.49e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—germ cell cancer	3.44e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—germ cell cancer	3.32e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—H2AFZ—germ cell cancer	3.22e-05	0.00135	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—germ cell cancer	3.21e-05	0.000312	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—germ cell cancer	3.09e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Methotrexate—germ cell cancer	3.06e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—germ cell cancer	3.06e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Methotrexate—germ cell cancer	3.04e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.01e-05	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	2.98e-05	0.00125	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KITLG—germ cell cancer	2.96e-05	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—OXT—germ cell cancer	2.95e-05	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Methotrexate—germ cell cancer	2.89e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	2.79e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—H2AFZ—germ cell cancer	2.73e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.66e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGF4—germ cell cancer	2.52e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.47e-05	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—OXT—germ cell cancer	2.33e-05	0.00098	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.32e-05	0.000974	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	2.29e-05	0.000965	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—H2AFZ—germ cell cancer	2.25e-05	0.000947	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—FGFR3—germ cell cancer	2.2e-05	0.000925	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—HRAS—germ cell cancer	2.18e-05	0.000918	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.17e-05	0.000911	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—H2AFZ—germ cell cancer	2.08e-05	0.000876	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KITLG—germ cell cancer	2.07e-05	0.000871	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AVP—germ cell cancer	2.02e-05	0.000852	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KIT—germ cell cancer	2.02e-05	0.000849	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGF4—germ cell cancer	1.99e-05	0.000837	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MYC—germ cell cancer	1.96e-05	0.000824	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.9e-05	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—H2AFZ—germ cell cancer	1.78e-05	0.000747	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KITLG—germ cell cancer	1.63e-05	0.000687	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—H2AFZ—germ cell cancer	1.6e-05	0.000674	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AVP—germ cell cancer	1.6e-05	0.000672	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—H2AFZ—germ cell cancer	1.58e-05	0.000664	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGFR3—germ cell cancer	1.54e-05	0.000648	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MYC—germ cell cancer	1.49e-05	0.000628	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.48e-05	0.000621	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.45e-05	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KIT—germ cell cancer	1.41e-05	0.000595	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—OXT—germ cell cancer	1.37e-05	0.000575	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGFR3—germ cell cancer	1.21e-05	0.000511	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC2A3—germ cell cancer	1.2e-05	0.000505	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CRABP1—germ cell cancer	1.19e-05	0.000499	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC22A3—germ cell cancer	1.18e-05	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGF4—germ cell cancer	1.17e-05	0.000491	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—germ cell cancer	1.15e-05	0.000484	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—germ cell cancer	1.13e-05	0.000477	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KIT—germ cell cancer	1.11e-05	0.000469	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—germ cell cancer	1.11e-05	0.000467	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—H2AFZ—germ cell cancer	1.04e-05	0.000439	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CRABP1—germ cell cancer	9.65e-06	0.000406	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KITLG—germ cell cancer	9.59e-06	0.000403	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—germ cell cancer	9.44e-06	0.000397	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AVP—germ cell cancer	9.37e-06	0.000394	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—germ cell cancer	8.72e-06	0.000367	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC2A3—germ cell cancer	7.92e-06	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC22A3—germ cell cancer	7.8e-06	0.000328	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—germ cell cancer	7.78e-06	0.000327	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—germ cell cancer	7.19e-06	0.000302	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGFR3—germ cell cancer	7.13e-06	0.0003	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KIT—germ cell cancer	6.54e-06	0.000275	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—germ cell cancer	6.39e-06	0.000269	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CRABP1—germ cell cancer	6.36e-06	0.000268	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—germ cell cancer	6.13e-06	0.000258	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—germ cell cancer	6.11e-06	0.000257	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—germ cell cancer	5.54e-06	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—germ cell cancer	5.45e-06	0.000229	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—germ cell cancer	5.04e-06	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—germ cell cancer	4.82e-06	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—germ cell cancer	3.6e-06	0.000151	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—germ cell cancer	2.96e-06	0.000124	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—germ cell cancer	2.83e-06	0.000119	CbGpPWpGaD
